Overview
Lobbying Costs
550,000€
Financial year: Jan 2018 - Dec 2018
Lobbyists (Full time equivalent)
2.25 Fte (5)
Lobbyists with EP accreditation
0
High-level Commission meetings
6
Lobbying Costs over the years
-
Info
CELGENE
EU Transparency Register
37955905654-37 First registered on 14 Apr 2011
Goals / Remit
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.
Main EU files targeted
Celgene works with European institutions to raise awareness of diseases with a high unmet medical need - such as rare diseases, rare cancers and immune and inflammatory diseases - to drive greater focus on patients with these underserved conditions. We seek cooperation in policy developments that improve regulatory processes for pharmaceuticals and ensure the right environment for research and industry in Europe. We foster debates around improved and equal access to innovative medicines for patients through open dialogues with European policy-makers.
We therefore monitor EU initiatives related to the registration and evaluation of medicines as well as the current EU policy debates on innovation in healthcare, Health Technology Assessment cooperation, access to medicines and intellectual property.Address
Head Office
Morris Avenue, 86
Summit NJ07901
UNITED STATESEU Office
Rue du Trône, 108
Bruxelles 1050
BELGIUM -
People
Total lobbyists declared
5
Employment time Lobbyists 75% 1 50% 2 25% 2 Lobbyists (Full time equivalent)
2.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Ms Esther BERDEN 21 Feb 2020 09 Apr 2020 Mr Erwan Gicquel 16 Jan 2020 09 Apr 2020 Emmanuel CHANTELOT 18 Dec 2019 09 Apr 2020 Silviu POPA 17 Oct 2019 09 Apr 2020 Ms Cassandre Sergent 20 Sep 2019 09 Apr 2020 Ms Esther BERDEN 19 Feb 2019 19 Feb 2020 Mr Erwan Gicquel 22 Jan 2019 16 Jan 2020 Emmanuel CHANTELOT 22 Jan 2019 18 Dec 2019 Ms Cassandre Sergent 01 Sep 2018 31 Aug 2019 Silviu POPA 14 Jun 2018 14 Jun 2019 Mr Adam PARNABY 31 Jan 2018 31 Jan 2019 Mr Erwan Gicquel 08 Dec 2017 07 Dec 2018 Emmanuel CHANTELOT 28 Nov 2017 28 Nov 2018 Ms Cassandre Sergent 31 Aug 2017 25 Aug 2018 Silviu POPA 20 Jul 2017 14 Jun 2018 Mr Erwan Gicquel 16 Dec 2016 08 Dec 2017 Emmanuel CHANTELOT 01 Nov 2016 01 Nov 2017 Ms Cassandre Sergent 30 Aug 2016 27 Aug 2017 Ms Laura GUTIERREZ 19 Jul 2016 02 Jul 2017 Silviu POPA 19 Jul 2016 02 Jul 2017 Ms Lugdivine Le Dez 19 Jul 2016 28 Jun 2017 Mr Christoph GLIESING 10 Oct 2015 14 Sep 2016 Ms Laura GUTIERREZ 05 Jun 2015 03 Jun 2016 Silviu POPA 05 Jun 2015 03 Jun 2016 Ms Caroline Correas 14 Nov 2014 10 Oct 2015 Ms Lugdivine Le Dez 14 Nov 2014 12 Nov 2015 Ms Laura GUTIERREZ 29 Jul 2014 05 Jun 2015 Serge De Ruysscher 26 Jun 2014 23 Apr 2015 Silviu POPA 14 Jun 2014 05 Jun 2015 Ms Lugdivine Le Dez 28 Nov 2013 14 Nov 2014 Ms Caroline Correas 01 Nov 2013 31 Oct 2014 Mr Julien Patris 21 Aug 2013 15 Aug 2014 Ms Laura GUTIERREZ 30 Jul 2013 27 Jul 2014 Mrs Cassandra Elsa Birgitta JULIN 11 Jan 2013 30 Mar 2013 Mrs Cassandra Elsa Birgitta JULIN 06 Feb 2012 01 Nov 2012 Mrs Laura GUTIERREZ 06 Feb 2012 01 Aug 2012 Mr Julien Claude PATRIS 24 Jan 2012 08 Feb 2013 Complementary Information
While several Celgene employees contribute to the company’s activities falling under the scope of the Transparency Register, only 5 Celgene employees spend more than 10% of their respective work time on this.
Person in charge of EU relations
Mr Emmanuel Chantelot (Executive Director, Government Relations and Policy, Worldwide Markets)
Person with legal responsibility
Mr Mark Alles (Chairman and Chief Executive Officer)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Celgene is a member of following organizations in Brussels:
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
American Chamber of Commerce to the European Union (AmCham EU)
Friends of Europe
European Policy CentreMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2018 - Dec 2018
Lobbying costs for closed financial year
550,000€
Other financial info
The estimated costs of Celgene arising from activities for the year 2018 covered by the Register include staff costs based on the full-time equivalents already declared, payment to third parties (e.g. fees for consultants) and membership and related fees for joining relevant networks and structures (e.g. trade associations).
This new estimate follows and is consistent with the guidance provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA). -
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
None
Other activities
None declared
Meetings
Meetings
6 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 30 Nov 2017 Location Brussels Subject Investment, innovation and IP protection Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists -
Date 27 Nov 2015 Location Brussels Subject Biopharmaceutical industry's contribution to jobs and growth Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Grzegorz Radziejewski (Cabinet member)
Other Lobbyists -
Date 27 Apr 2015 Location Brussels, Belgium Subject Biopharmaceutical industry Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Kaius Kristian Hedberg (Cabinet member)
- Rolf Carsten Bermig (Cabinet member)
-
Date 04 Feb 2015 Location Brussels Subject Access to innovative medicine Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
Other Lobbyists -
Date 04 Feb 2015 Location Brussels Subject Janssen EMEA Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Aura Salla (Cabinet member)